Laidlaw Capital Markets acts as Co-Lead Bookrunner on Cingulate Inc’s (CING) $25,000,000 Offering.dan2021-12-10T14:29:03-05:00December 10th, 2021|Read More
Laidlaw Capital Markets is Financial Advisor on MEI Pharma Inc’s $52,325,000 Follow-On Offeringdan2021-12-10T05:25:17-05:00December 10th, 2021|Read More
Laidlaw Capital Markets is Financial Advisor on EyePoint Pharmaceuticals Inc’s $115,400,000 Follow-On Offering.dan2021-11-10T05:32:23-05:00November 10th, 2021|Read More
Laidlaw Capital Markets is Co-Manager in Guggenheim Active Allocation Fund Initial Public Offeringdan2021-11-05T03:05:10-04:00November 5th, 2021|Read More
Laidlaw Capital Markets is Co-Manager in Blackrock ESG Capital Allocation Trust $2,040,000,000 Initial Public Offeringdan2021-09-25T02:44:33-04:00September 25th, 2021|Read More
Stay In Touch